Table 3.
Relationship between pH2AX expression and different clinicopathological parameters
| pH2AX expression | P value | |||
|---|---|---|---|---|
|
|
||||
| High (%) | Low (%) | |||
| Age | ≤50 y | 27 (72.9) | 10 (27.1) | 0.149 |
| >50 y | 29 (58) | 21 (42) | ||
| Histology | Serous | 28 (65.1) | 15 (35.9) | 0.497 |
| Mucos | 3 (50) | 3 (50) | ||
| Clear cell | 11 (78.6) | 3 (21.4) | ||
| Endometrioid | 4 (44.4) | 5 (55.6) | ||
| Others | 10 (76.9) | 3 (23.1) | ||
| FIGO stage | I+II | 18 (66.7) | 9 (23.3) | 0.764 |
| III+IV | 38 (63.3) | 22 (26.7) | ||
| Differentiation | Grade 1&2 | 12 (70.6) | 5 (29.4) | 0.359 |
| Grade 3 | 32 (58.2) | 23 (41.8) | ||
| Lymph node metastasis | negative | 24 (61.5) | 15 (38.5) | 0.917 |
| positive | 9 (60) | 6 (40) | ||
| Resident lesions | none | 23 (56.1) | 18 (43.9) | 0.229 |
| ≤1 cm | 13 (65) | 7 (35) | ||
| >1 cm | 15 (78.9) | 4 (21.1) | ||
| Chemotherapy response | sensitive | 25 (53.2) | 22 (46.8) | 0.025 |
| resistant | 20 (80) | 5 (20) | ||